Brainwave: Cognition gets ideas about effect of Alzheimer's prospect from midphase data

Cognition Therapeutics has released data on the effect its Alzheimer’s disease drug candidate had on an exploratory endpoint in a small clinical trial, offering another look at how the molecule acts on the brain as the biotech heads toward more important readouts.